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Abstract
Background Anastomotic leakage is a feared complica-
tion following colorectal surgery and is associated with
early and long-term morbidity and mortality. The presacral
cavity as the result of leakage can be treated with an endo-
sponge (B-Braun Medical). The aim of this study was to
assess the effectiveness of endo-sponge treatment of the
presacral cavity as the result of anastomotic leakage in the
Netherlands.
Methods Between July 2006 and April 2008, 16 patients
(M/F = 9:7) with median age 64 years (range 19–
78 years) who underwent surgery for rectal cancer
(n = 13) or ulcerative colitis (n = 3) were treated with the
endo-sponge treatment after anastomotic leakage.
Results Of the 16 patients, eight patients started with the
endo-sponge treatment within 6 weeks after the initial
surgery. In these patients the endo-sponge was placed after
a median of 24 days (range 13–39 days) following surgery.
In the remaining eight patients the endo-sponge treatment
was started later than 6 weeks after the initial surgery. In
this group there was a median of 74 days (range 43–
1,602 days) between surgery and the start of endo-sponge
placement. There was closure in six out of eight patients
(75%) in the group that started with the endo-sponge
treatment within 6 weeks of surgery compared with three
out of eight patients (38%) in the group that started later
(p = 0.315). Closure was achieved in a median of 40
(range 28–90) days with a median number of 13 sponge
replacements (range 8–17).
Conclusions Endo-sponge placement can be helpful in
the treatment for anastomotic leakage after colorectal sur-
gery and might prevent a chronic presacral sinus. However,
it is not yet clear if this new treatment modality results in
quicker healing.
Keywords Anastomotic leakage  Rectal surgery 
Vacuum-assisted closure
Anastomotic leakage is a serious and feared complication
following colorectal surgery and is associated with early
and long-term morbidity and mortality [1–4]. Particularly,
(low) anterior resections are associated with a high leakage
rate ranging from 1% to 24% [5, 6]. For this reason many
surgeons prefer defunctioning the colorectal or coloanal
anastomosis using a loop ileostomy. Anastomotic leakage
of a functioning anastomosis mostly requires surgical re-
intervention to fashion a loop ileostomy and to drain the
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complications.
Defunctioning of a low anastomosis by loop ileostomy
does not prevent the leakage to occur, but diminishes the
septic sequelae. Mostly, a presacral cavity originates from
the site of the leakage. The cavity probably heals sponta-
neously when it is small. When it is large, it might delay
the closure of the ileostomy and probably results in a
devastating future function of the neorectum [7, 8]. Closure
of the loop ileostomy in the presence of chronic presacral
sinus is considered hazardous since septic complications or
bad function can be expected in some cases.
In the treatment of various wounds vacuum-assisted
therapy is often used to achieve wound closure [9].
Recently, the application of local vacuum sponge treatment
has shown to be effective to treat locally contained anas-
tomotic leakage after low anterior anastomosis in rectal
cancer patients. In a recent publication by Weidenhagen
et al. [10], a series of 29 patients with anastomotic leakage
following rectal resection for malignant disease were
treated with endo-sponge. The endo-sponge facilitates
closure of the presacral space by negative pressure of the
endo-sponge, ensuring continuous drainage and thereby
infection control, increased blood ﬂow and therefore the
stimulation of granulation tissue and reduction of the size
of the cavity. In 28 out of the 29 patients described there
was complete closure of the cavity.
The aim of this study was to assess the effectiveness of
endo-sponge (B-Braun Medical B.V., Melsungen, Ger-
many) treatment of presacral cavities associated with
anastomotic leakage.
Materials and methods
Patient characteristics
Between July 2006 and April 2008, a series of patients with
a presacral cavity after anastomotic leakage were treated by
using the endo-sponge. All hospitals that had used the
endo-sponge were contacted to collect data of experience
with the endo-sponge. The endo-sponge had been used in
patients following anastomotic leakage after low anterior
resections for malignant disease or after restorative proc-
tocolectomy with ileoanal pouch anastomosis for ulcerative
colitis.
After surgery, when anastomotic leakage was suspected
a computed tomography (CT) scan was performed in the
majority of the cases. Using ﬂexible endoscopy, the pres-
ence of an abscess cavity was conﬁrmed. Subsequently a
diverting stoma was routinely constructed when this had
not been done during the primary operation. Primary out-
come parameters were closure of the cavity and the ability
to close the ileostomy. Factors associated with successful
closure were analyzed, e.g., time of initiation of endo-
sponge treatment after surgery, and experience with endo-
sponge treatment (number of cases treated).
Approval of the Medical Ethics Committees was not
necessary, since in the Netherlands for nonexperimental
clinical case series such as this approval is not required.
Endo-sponge treatment
The endo-sponge is an open-pored polyurethane sponge (B.
Braun Medical B.V., Melsungen, Germany). A photograph
of the introduction set is presented in Fig. 1. The sponge is
installed transanally after examination and rinsing (saline
0.9%) of the abscess cavity using a small-calibre ﬂexible
gastroscope (GIF-100 Video Gastroscope, Olympus,
9.8 mm diameter). The length and size of the abscess
cavity is estimated and the size of the endo-sponge is cut
accordingly. When the cavity is too large for one sponge,
multiple sponges are placed. After introduction of a small-
calibre gastroscope into the deepest point of the cavity, a
plastic tube, positioned over the gastroscope, is advanced
into the deepest point of the cavity. After withdrawal of the
gastroscope, the endo-sponge is inserted through the
lubricated tube by using a pushing probe, while retracting
the plastic tube. Next, the sponge is connected to a low-
vacuum suction bottle (Redyron
 TRANS PLUS suction
device), creating a constant negative pressure in the
sponge. The correct positioning of the sponge is endo-
scopically checked. Fixation of the sponge is not necessary,
because low-pressure suction ﬁxes the sponge in the
abscess cavity. The endo-sponge is changed every 3–
4 days to prevent the tissue from growing into the sponge
causing painful sponge exchanges. Saline (0.9%) is intro-
duced into the sponge just before removal to facilitate the
painless extraction. Some hospitals use lidocaine instead of
saline for this matter. During every endo-sponge exchange
the size of the endo-sponge is reduced. Closure of the sinus
Fig. 1 Endo-sponge
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contrast enema.
Data collection
Patients’ charts were reviewed and data was extracted on
demographic data, body mass index (BMI), preoperative
chemo and/or radiotherapy, type and indication of surgery
(possible ileostomy/colostomy), level of anastomosis,
morbidity, mortality, time between surgery and start of
treatment, duration of endo-sponge treatment, amount of
sponge exchanges, sponge related complications, follow-
up, and short-term outcome.
Statistical analysis
Continuous data are presented as median values (range)
unless otherwise speciﬁed. Categorical data are presented
as frequencies or percentages. For the comparison of cat-
egorical variables, the chi-square or Fisher exact test was
used. A p-value of 5% or lower was considered statistically
signiﬁcant. Statistical analysis was performed using SPSS
software version 14.0.2 for Windows (SPSS, Chicago, IL,
USA).
Results
Patient characteristics
In total 16 patients (M/F = 9:7) with median age 64 years
(range 19–78 years) were included (Table 1). Thirteen
patients had undergone surgery for rectal cancer and three
for therapy-resistant ulcerative colitis. Nine of the 13
patients who underwent colorectal resection for malignant
disease received preoperative radiotherapy. Two patients
had chemoradiation preoperatively. In 4 patients the pro-
cedure was performed laparoscopically and in 12 patients
an open procedure was performed. The anastomosis was
constructed at a median height of 5 cm (range 2–8 cm)
from the anal verge. During the initial operation a de-
functioning ileostomy was created in eight patients. In
seven patients the diverting stoma was created after the
discovery of the anastomotic leakage. In one patient a
previously present diverting loop ileostomy was changed
into an end ileostomy.
Outcome
Postoperatively, anastomotic leakage was diagnosed by CT
scan in 15 patients. In one patient the leakage was dis-
covered by ﬂexible endoscopy. None of the patients had
generalized peritonitis during the use of the endo-sponge.
After endoscopic conﬁrmation of the abscess cavity the
endo-sponge was placed. The median duration between the
initial surgery and the discovery of the leakage was
11 days (range 3–150 days). Of the 16 patients, 8 patients
started with the endo-sponge treatment within 6 weeks
after the initial surgery. In these patients the endo-sponge
was placed after a median of 24 days (range 13–39 days)
following surgery (Table 2). In the remaining eight patients
the endo-sponge treatment was started later than 6 weeks
after the initial surgery. In this group there was a median of
74 days (range 43–1,602 days) between surgery and the
start of the endo-sponge placement. Experience in the
different hospitals ranged from one to ﬁve patients in the
study period. The median number of sponges initially
placed ranged from one to three. In six patients the endo-
sponge was placed under general anaesthesia. In three
patients replacements were performed under a light seda-
tive (5 mg midazolam). The remaining seven patients
underwent sponge placement without any anaesthesia.
Table 1 Characteristics of patients with anastomotic leakage that
underwent endo-sponge treatmen
Variable n = 16
Male/female (n) 9:7
Age (years), median (range) 64 (19–78)
Indication for surgery
Benign 3
Malignancy 13
BMI (kg/m
2), median (range) 26 (23–31)
Preoperative treatment
Radiotherapy 9
Chemoradiation 2
Type of surgery
Open 12
Laparoscopic 4
Anastomosis level (cm), mean (range) 5 (2–8)
Stoma created during primary surgery 8
BMI body mass index
Table 2 Results of the use of the endo-sponge
Variable n = 16
Start amount sponges, median (range) 1 (1–3)
Time between surgery and start sponge treatment
(days), median (range)
41 (13-1, 602)
B6 weeks (n = 8, days) 24 (13–39)
[6 weeks (n = 8, days) 74 (43–1,602)
Time until closure (days), median (range) 40 (28–90)
Number of sponge exchanges, median (range) 13 (8–17)
Closure of abcsess cavity, n (%) 9 (56%)
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group in 9 out of 16 patients (56%). Closure was achieved
in a median of 40 (range 28–90) days with a median
amount of 13 sponge replacements (range 8–17). There
was closure in six out of eight patients (75%) in the group
that started with the endo-sponge treatment within 6 weeks
of surgery compared with three out of eight patients (38%)
in the group that started later (p = 0.315). In the malignant
group in six patients (46%) the endo-sponge treatment was
successful compared with three out of three patients in the
benign group (p = 0.213).
In one patient the sponge exchange was complicated by
a bleeding in abscess cavity (500 cc blood loss). Endo-
sponge treatment was stopped in one patient after 13
exchanges because the vacuum therapy was very painful. A
possible explanation for this was that the abscess cavity
was close to the hypogastric plexus. In a third patient, with
a nearly complete dehiscent anastomosis, the sponge
treatment was stopped after eight exchanges because there
was insufﬁcient progress in the closure of the cavity.
Finally an end colostomy was constructed. In two patients,
due to recurrent abscesses, an intersphincteric proctectomy
was performed.
Median follow-up after closure of the abscess cavity was
4 months (range 2–16 months).
Out of nine patients with a closed abscess cavity the
stoma had been closed in ﬁve patients. One of these
patients underwent relaparotomy after stoma closure as a
result of anastomotic leakage of the short bowel anasto-
mosis. A diverting ileostomy was constructed. Two
patients are currently on the waiting list to close the stoma.
In the remaining two patients the stoma is considered
deﬁnitive because of patient preference or metastatic
disease.
Discussion
The present study shows that the endo-sponge is a prom-
ising device and could potentially be helpful in the
treatment of anastomotic leakage after colorectal surgery.
Furthermore, it may prevent the development of a chronic
presacral sinus.
Anastomotic leakage after surgery is a complication that
has major consequences for the patient, resulting in major
morbidity and even mortality [1, 2, 11, 12]. Small anas-
tomotic leakages after surgery in the pelvic area can
potentially be treated by a wait-and-see policy. This is not
the case when the leakage involves a signiﬁcant part of the
circumference. This frequently leads to a large presacral
sinus which often requires additional surgical procedures
and long-term drainage of the abscess cavity. Furthermore,
the purulent discharge and the often accompanying foul
odour have an inevitable inﬂuence on the patient’s quality
of life. The prolonged pelvic sepsis and ﬁbrosis is held
responsible for impaired long-term neorectum function
after ileostomy closure in many of those patients [7, 8].
Aggressive treatment of the presacral abscess enforcing
quick resolution of the pelvic sepsis might be important for
long-term outcome.
Following the application of vacuum sponges for the
closure of abdominal wounds [13], the endo-sponge was
developed for the resolution of presacral abscess cavities as
a result of anastomotic leakages following colorectal
surgery.
In the literature a small group of patients (n = 4) with
signiﬁcant anastomotic leakage after rectal resection that
were treated in 2004 with a transanal vacuum-assisted
closure (VAC) has been reported by Nagell and Holte [14].
All patients had a protective ileostomy before the start of
the vacuum treatment. The median healing time of these
patients was 51 (range 43–195) days.
Weidenhagen et al. [10] described a series of 29 patients
treated with endo-sponge. The majority of these patients
underwent surgery for malignant disease and nine patients
received preoperative chemoradiation. Deﬁnitive closure
was achieved in 28 of the 29 patients (97%). Mean total
duration of the treatment was 34 days (range 4–79 days)
and the number of sponge exchanges was 11 (range 1–27).
Twenty-two out of the 25 patients with a protecting stoma
the stoma could be closed after the abscess cavity was
obliterated. Mees et al. described a small series of ﬁve
patients with a presacral abscess following anastomotic
leakage after low anterior resection and restorative proc-
tocolectomy [15]. Median time to closure was 45 days
(range 32–68 days).
In the present series, closure of the abscess cavity after
low anastomotic leakage after colorectal surgery was
achieved in 9 of 16 patients. This is lower than reported by
Weidenhagen et al. in their series (97%). In our series
endo-sponge treatment was not started shortly after the
initial surgical procedure in all patients. Although not
signiﬁcantly, the results were better in the group of patients
that started within 6 weeks after surgery compared with the
group that started later than 6 weeks (75% versus 56%). A
difference in closure rate between the groups that started
early compared to late can be explained by the develop-
ment of ﬁbrosis of the neorectum precluding alignment of
the bowel with the abscess cavity. As a result, endo-sponge
treatment of chronic presacral sinuses probably has an
unsatisfactory effect. Up to now ﬁve out of nine patients
with a closed cavity had their stoma removed and in two
cases stoma closure is planned.
In these series, all patients had a diverting stoma after
anastomotic leakage. The question is whether it is neces-
sary to divert the faecal stream when an endo-sponge is
1382 Surg Endosc (2009) 23:1379–1383
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effectively, it prevents faeces and debris being pushed into
the sinus. In the series of Weidenhagen et al. four patients
were treated without the construction of a diverting stoma.
With the current endoluminal vacuum therapy patients
have to undergo sponge exchanges every 3–4 days. This is
done to prevent tissue growing into the sponge causing
painful sponge exchanges. In the majority of the patients in
these series the early exchanges were done in a clinical
setting. After a few sponge exchanges most patients were
discharged and treated in an outpatient setting. The patient
has to return to the hospital two times a week. This cycle
has a considerable impact on the patient and is demanding
for the team performing the sponge exchanges in terms of
time, effort, and availability of operating room and/or
endoscopy suite space. Furthermore the costs are consid-
erable. A complete set with the vacuum bottle that is used
for one sponge exchange costs €195.
Until now, there is insufﬁcient literature to determine
whether endo-sponge treatment is superior to wait-and-see
policy after faecal deviation. There is enough information
on the different aspects of anastomotic leakage, e.g.,
potential risk factors and oncological outcome [3, 4, 5, 6,
11, 16]. However, there are only few reports on the long-
term outcome of anastomotic leakage after colorectal sur-
gery in terms of functional outcome. A series of 19 patients
with a median follow-up duration of 30 months was
reported by Hallbook and Sjodahl [7]. It showed that
neorectal volume and compliance were signiﬁcantly
reduced in patients with anastomotic leakage. Nesbakken
et al. [8] reported on the functional outcome after anasto-
motic leakage following low anterior resection for rectal
cancer. In their series, 11 patients with anastomotic leakage
were compared with patients without leakage after surgery.
In the group with leakage the neorectal capacity was sig-
niﬁcantly lower compared with the group without, 120
versus 180 ml (p = 0.04), respectively. Furthermore, sig-
niﬁcantly more evacuation problems were reported.
In conclusion, endo-sponge placement can be helpful in
treatment of anastomotic leakage after colorectal surgery
and may prevent chronic presacral sinus. Starting early
with endo-sponge treatment is probably more effective
than late treatment of the presacral sinus. The long-term
follow-up and functional outcome of the neorectum must
be awaited.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which
permits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Ptok H, Marusch F, Meyer F et al (2007) Impact of anastomotic
leakage on oncological outcome after rectal cancer resection. Br J
Surg 94(12):1548–1554
2. Jung SH, Yu CS, Choi PW et al (2008) Risk factors and onco-
logic impact of anastomotic leakage after rectal cancer surgery.
Dis Colon Rectum 51(6):902–908
3. Jestin P, Pahlman L, Gunnarsson U (2008) Risk factors for
anastomotic leakage after rectal cancer surgery: a case–control
study. Colorectal Dis 10(7):715–721
4. Lee WS, Yun SH, Roh YN et al (2008) Risk factors and clinical
outcome for anastomotic leakage after total mesorectal excision
for rectal cancer. World J Surg 32(6):1124–1129
5. Rullier E, Laurent C, Garrelon JL et al (1998) Risk factors for
anastomotic leakage after resection of rectal cancer. Br J Surg
85(3):355–358
6. Matthiessen P, Hallbook O, Andersson M, Rutegard J, Sjodahl R
(2004) Risk factors for anastomotic leakage after anterior resec-
tion of the rectum. Colorectal Dis 6(6):462–469
7. Hallbook O, Sjodahl R (1996) Anastomotic leakage and func-
tional outcome after anterior resection of the rectum. Br J Surg
83(1):60–62
8. Nesbakken A, Nygaard K, Lunde OC (2001) Outcome and late
functional results after anastomotic leakage following mesorectal
excision for rectal cancer. Br J Surg 88(3):400–404
9. Hunter JE, Teot L, Horch R, Banwell PE (2007) Evidence-based
medicine: vacuum-assisted closure in wound care management.
Int Wound J 4(3):256–269
10. Weidenhagen R, Gruetzner KU, Wiecken T, Spelsberg F, Jauch
KW (2007) Endoscopic vacuum-assisted closure of anastomotic
leakage following anterior resection of the rectum: a new method.
Surg Endosc 22(8):1818–1825
11. Law WL, Chu KW (2004) Anterior resection for rectal cancer
with mesorectal excision: a prospective evaluation of 622
patients. Ann Surg 240(2):260–268
12. Wind J, Koopman AG, van Berge Henegouwen MI et al (2007)
Laparoscopic reintervention for anastomotic leakage after pri-
mary laparoscopic colorectal surgery. Br J Surg 94(12):1562–
1566
13. Mendonca DA, Papini R, Price PE (2006) Negative-pressure
wound therapy: a snapshot of the evidence. Int Wound J
3(4):261–271
14. Nagell CF, Holte K (2006) Treatment of anastomotic leakage
after rectal resection with transrectal vacuum-assisted drainage
(VAC). A method for rapid control of pelvic sepsis and healing.
Int J Colorectal Dis 21(7):657–660
15. Mees ST, Palmes D, Menninger R et al (2008) Endo-vacuum
assisted closure treatment for rectal anastomotic insufﬁciency.
Dis Colon Rectum 51(4):404–410
16. Lipska MA, Bissett IP, Parry BR, Merrie AE (2006) Anastomotic
leakage after lower gastrointestinal anastomosis: men are at a
higher risk. ANZ J Surg 76(7):579–585
Surg Endosc (2009) 23:1379–1383 1383
123